Pathways | myADLM.org

Scientific Pathways

Explore ADLM 2026 through Scientific Pathways that connect sessions across topics, helping you discover content that matches your interests and build a personalized meeting experience.

Full Program Add to registration

These six pathways are cross-cutting and dynamic, complementing core topics while highlighting areas of high impact and market relevance in clinical laboratory medicine. They are designed to guide you through leading-edge science, emerging trends, and innovations shaping the field.

AI, Data Science, & the Digital Laboratory
Next-Generation Biomarkers
Diagnostics Beyond the Central Laboratory
Precision Health and Personalized Care
Public Health and Laboratory Response
Innovations in Clinical Microbiology

You can search pathway sessions for dates and times and all ADLM 2026 sessions using the online session.

AI, Data Science, & the Digital Laboratory

Artificial intelligence, advanced analytics, and digital technologies are transforming every aspect of laboratory medicine—from workflow optimization and decision support to data-driven patient care. Explore this pathway to learn how laboratories are harnessing data, automation, and emerging technologies to improve quality, efficiency, and clinical impact. Explore data science (excludes Roundtables)

ADLM University Full Day Course (6-hour)‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎‎ ‎ ‎ ‎‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎‎ ‎ ‎ ‎ ‎ ‎‎‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎

191307 Practical considerations in evaluating and implementing AI solutions for today’s clinical laboratorian
Scientific Session

32445 Navigating reimbursement and coding: The basics, AI, and emerging healthcare technologies

32446 Petri dishes and pixels: Applying digital imaging solutions to contemporary clinical microbiology practice

32225 Life after AI deployment: A conversation on effective real-world performance monitoring

32226 First, do no harm: Ethics at the crossroads of scientific integrity, AI, and DTC testing

33102 Academy distinguished abstracts: Precision oncology diagnostics: AI, blood-based biomarkers, and longitudinal monitoring

33108 ADLM Healthcare Forum: Future regulation and reimbursement for software and AI in the clinical laboratory

33228 Academy guidance document on data analytics: Advancing data analytics maturity in the clinical laboratory for a data-driven future

34106 The integration journey: Preparing clinical laboratorians for EHR/LIS implementation

35102 Advancing equity in maternal drug testing: From ethical challenges to informatics solutions
Roundtable

42105/52205 Reimagining the clinical laboratory: AI applications for today and the future

42106/52206 AI-driven precision medicine: Integrating wearable data streams to stratify cardio-metabolic risk and management

43104/53204 Data literacy in the clinical lab: What do I need to know?

43106/53206 The future of middleware solutions: Benefits, considerations, and the emergence of AI

43107/53207 Complex data analysis for dummies: Using ChatGPT prompts to enhance data analysis through coding

43125/53225 Understanding machine learning algorithms: Key considerations, it’s not magic, it’s math

43131/53231 Automate, analyze, act: Leveraging Excel for lab data efficiency

44114/54214 Artificial intelligence driven supply chain management in clinical laboratories

Next-Generation Biomarkers

Novel biomarkers are reshaping how diseases are detected, monitored, and managed, enabling earlier intervention and more precise clinical decisions. Follow this pathway to discover the latest advances in biomarker science, from neurodegenerative disease and cardiovascular health to cancer and beyond. Explore novel biomarkers (excludes Roundtables)

Plenary‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎

13001 Alzheimer disease biomarkers in Down syndrome

15001 Mass spectrometry-based discovery and translation of novel biomarkers into immune-based therapies for cancer
Scientific Session

32101 Biomarkers of traumatic brain injury: New guidance from the National Institute of Neurological Disorders and Stroke

32103 Moving beyond creatinine to evaluate kidney function through novel biomarker panels

32447 Clocking biological time: Measuring, standardizing, and influencing biological age

32221 Enhancing CVD care: Leveraging new AHA/ACC guidelines, treatments, risk assessments, and innovative functional assays

32223 Biomarkers for acute kidney injury: From physiology to practice with new clinical guidance

33102 Academy distinguished abstracts: Precision oncology diagnostics: AI, blood-based biomarkers, and longitudinal monitoring

33105 Transforming Alzheimer’s care: Implications of new clinical guidance

33222 The sFlt-1:PlGF ratio in the evaluation of preeclampsia

34222 Lipoprotein(a) could be the next public health revolution: Are clinical laboratories ready for the challenge?

34227 Current and future landscape of tumor markers in clinical use: Applications, challenges, and perspectives

35101 Beyond blood: The frontier of noninvasive fluid diagnostics

35103 Update on thyroid function tests and efforts to improve their reliability
Roundtable

42109/52209 Navigating clinical implementation challenges for traumatic brain injury (TBI) biomarker assays

42113/52213 Neurofilament light chain testing from start to finish: Challenges and implementation strategies for multiple sclerosis management

42125/52225 Exerkines: From molecular messengers of exercise to clinical biomarkers of health and resilience

42127/52227 Are we there yet? Clinical implementation of multi-cancer early detection (MCED) tests for preventive oncology

43108/53208 Alzheimer’s disease biomarkers: Assay selection, performance considerations, and result interpretation

43111/53211 Status of testosterone and estradiol testing in light of new guidelines and recommendations

43128/53228 Impact of sFlt-1 and PlGF testing on the management of women with suspected preeclampsia in a high-risk obstetrics unit

44111/54211 Emerging blood-based biomarkers in neurodegenerative disease diagnosis and management

Diagnostics Beyond the Central Laboratory

Diagnostic testing is increasingly moving closer to patients through point-of-care testing, remote sampling, wearables, and home-based technologies. This pathway highlights innovations that are expanding access to testing and bringing timely diagnostic insights wherever care is delivered. Explore POCT and beyond (excludes Roundtables)

ADLM University Full Day Course (6-hour)‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎‎ ‎ ‎ ‎ ‎ ‎

191308 Regulatory round-up: Hands-on workshop for navigating common laboratory deficiencies in point-of-care testing (POCT)
Plenary

12001 Laboratory diagnostics for space medicine
Roundtable

42110/52210 Alternative matrix samples: Challenges in body fluid testing and assay validation

42131/52231 Advanced care at home experience at Mayo Clinic and role of lab medicine

43101/53201 Point of care on the fast track: Managing growth, complexity, and compliance for large POCT programs

43103/53203 Raising the bar in point-of-care waived testing beyond regulatory minimums

43114/53214 Unifying POCT lab critical result notification documentation with analytics insight

44101/54201 Empowering point-of-care excellence: Optimizing provider-performed microscopy (PPM) testing

44102/54202 POCT in the autopsy suite: Screening for ketoacidosis as a cause of death

44106/54206 ADLM remote sampling task force: Review and management topics

44128/54228 What a pair: Implementing point of care viscoelastic testing in pediatric care
Scientific Session

32104 Wearable devices for diagnostics, is this point-of-care testing?

32222 Newborn screening across Europe and the USA, what can we learn from each other?

32224 POCT across the continuum: From real-time results to measurable impact

33226 Addressing scientific gaps in POCT

34221 Patient centric sampling for clinical diagnostics: Overcoming barriers to routine adoption

34228 Alternative sampling for rapid toxicology screening by mass spectrometry

35101 Beyond blood: The frontier of noninvasive fluid diagnostics

Precision Health and Personalized Care

Laboratory medicine is at the heart of a healthcare model that is becoming more individualized, predictive, and targeted. Explore this pathway to see how biomarkers, genetics, risk stratification, and advanced diagnostics are helping tailor prevention, diagnosis, and treatment to the unique needs of each patient. Explore precision medicine (excludes Roundtables)

Plenary‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎

11001 Diabetes prevention and treatment: A personal odyssey from bench to bedside

13001 Alzheimer disease biomarkers in Down syndrome
Scientific Session

32103 Moving beyond creatinine to evaluate kidney function through novel biomarker panels

32108 Beyond clinical care: Ethical, legal, and social implications of third-party uses of DNA

32447 Clocking biological time: Measuring, standardizing, and influencing biological age

32221 Enhancing CVD care: Leveraging new AHA/ACC guidelines, treatments, risk assessments, and innovative functional assays

33101 Clinical Chemistry Journal hot topics: New approaches to personalized reference ranges

33105 Transforming Alzheimer’s care: Implications of new clinical guidance

33222 The sFlt-1:PlGF ratio in the evaluation of preeclampsia

34102 Hypertensive disorders of pregnancy: Cardiovascular implications

34107 Critical review and update of clinical guidelines for immune-mediated conditions: ANA reporting, antiphospholipid syndrome and multiple sclerosis

34222 Lipoprotein(a) could be the next public health revolution: Are clinical laboratories ready for the challenge?

34227 Current and future landscape of tumor markers in clinical use: Applications, challenges, and perspectives

35102 Advancing equity in maternal drug testing: From ethical challenges to informatics solutions
Roundtable

42106/52206 AI-driven precision medicine: Integrating wearable data streams to stratify cardio-metabolic risk and management

42113/52213 Neurofilament light chain testing from start to finish: Challenges and implementation strategies for multiple sclerosis management

42124/52224 Serology tests for celiac disease diagnosis and follow up in children

42127/52227 Are we there yet? Clinical implementation of multi-cancer early detection (MCED) tests for preventive oncology

43108/53208 Alzheimer’s disease biomarkers: Assay selection, performance considerations, and result interpretation

43122/53222 Beyond LDL-C: Case-based algorithms for complex lipid and lipoprotein profiles

43128/53228 Impact of sFlt-1 and PlGF testing on the management of women with suspected preeclampsia in a high-risk obstetrics unit

43130/53230 Therapeutic drug monitoring for hydroxychloroquine; teaching an old drug new tricks?

44111/54211 Emerging blood-based biomarkers in neurodegenerative disease diagnosis and management

44124/54224 Interpreting high-sensitive cardiac troponin results: Sex-specific or uniform upper reference limits?

44130/54230 Phosphatidylethanol (Peth) and post-liver transplant complications

Public Health and Laboratory Response

Laboratories play a critical role in protecting communities through disease surveillance, screening, outbreak response, and health equity initiatives. This pathway showcases how laboratory medicine supports public health preparedness, population health, and the rapid response needed to address emerging healthcare challenges. Explore public health response (excludes Roundtables)

Plenary‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎

14001 Advances in screening for cervical cancer both in the United States and globally
Scientific Session

32106 Tick-borne diseases: Beyond Lyme disease

32108 Beyond clinical care: Ethical, legal, and social implications of third-party uses of DNA

32222 Newborn screening across Europe and the USA, what can we learn from each other?

32226 First, do no harm: Ethics at the crossroads of scientific integrity, AI, and DTC testing

32227 Measuring what matters: A practical framework for advancing equitable healthcare, diversity, equity, and inclusion in laboratory medicine

33109 Recreational use of nitrous oxide: Clinical cases and laboratory detection

33229 Clinical laboratory realities for effective overdose biosurveillance

34102 Hypertensive disorders of pregnancy: Cardiovascular implications

34105 The shot not taken: Dangers of declining vaccination rates and impacts to the lab

34222 Lipoprotein(a) could be the next public health revolution: Are clinical laboratories ready for the challenge?
Roundtable

42111/52211 Emerging environmental toxins: PFAS forever chemicals and beyond

42122/52222 Blood culture contamination rates: Collaboration for sustainable improvements

42127/52227 Are we there yet? Clinical implementation of multi-cancer early detection (MCED) tests for preventive oncology

43112/53212 Ferritin cutoffs and iron deficiency: Harmonizing manufacturer reference intervals with recent guidelines to prevent missed diagnosis

43123/53223 HIV diagnostics: 40 years later!

44115/54215 Exploring the solutions to hospitalization-associated iatrogenic anemia

44118/54218 From volume to value: Improving the outpatient lab requisition through evidence-based test selection

44129/54229 Which specimen is best? Optimizing clinical toxicology workflows for the detection of in utero drug exposure

Innovations in Clinical Microbiology

Advances in microbiology are accelerating the detection, characterization, and management of infectious diseases. Follow this pathway to explore emerging technologies, molecular approaches, antimicrobial resistance strategies, and other innovations that are shaping the future of infectious disease diagnostics. Explore clinical microbiology (excludes Roundtables)

Plenary‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎

14001 Advances in screening for cervical cancer both in the United States and globally
Scientific Session

32106 Tick-borne diseases: Beyond Lyme disease

32446 Petri dishes and pixels: Applying digital imaging solutions to contemporary clinical microbiology practice

33106 Behind the bench: Navigating safety and science in prion disease testing

33225 Parasitology in the clinical lab, it’s not just for micro anymore

34105 The shot not taken: Dangers of declining vaccination rates and impacts to the lab

34225 Confronting antimicrobial susceptibility testing challenges: Tools from CLSI
Roundtable

42102 Sepsis diagnostics today and tomorrow: From procalcitonin and lactate to new FDA-cleared assays and AI-driven portable MS

42122 Blood culture contamination rates: Collaboration for sustainable improvements

43123 HIV diagnostics: 40 years later!

44122 Fungal taxonomy updates, Candida auris, and antifungal resistance testing in clinical laboratories

Join ADLM

ADLM professional members save up to $550 on ADLM 2026. Join for just $275 a year and enjoy year-round benefits.

join and renew

Explore what's next at the expo

Fuel your curiosity at the ADLM Clinical Lab Expo — the world’s leading exposition for laboratory medicine. Explore innovative technologies and practical, lab-ready solutions that will spark new ideas and possibilities.

Learn More

Scientific Pathways

AI, Data Science, & the Digital Laboratory

Scientific Session

Roundtable

Next-Generation Biomarkers

Scientific Session

Roundtable

Diagnostics Beyond the Central Laboratory

Plenary

Roundtable

Scientific Session

Precision Health and Personalized Care

Scientific Session

Roundtable

Public Health and Laboratory Response

Scientific Session

Roundtable

Innovations in Clinical Microbiology

Scientific Session

Roundtable